A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study

January 13, 2017

Type of Cancer

Lymphoma

Site

Hackensack

Sponsor

Janssen

Protocol Number

PCI32765CAN3001-EXT

To Learn More Call

(201)-510-0950